The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

Add Yahoo as a preferred source to see more of our stories on Google. Beta Bionics said it plans to integrate its ILet Bionic Pancreas automated insulin delivery system with a glucose-ketone sensor ...

BOSTON, July 12, 2018 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a medical technology company leveraging life-long, machine-learning, artificial intelligence to develop and commercialize the iLet Bionic ...

CEO Sean Saint opened the call by highlighting "strong performance in the third quarter" and updated annual projections for 2025. He cited record new patient starts and increased usage of the pharmacy ...

Beta Bionics' pharmacy channel exploded 153% in the quarter as the iLet Bionic Pancreas scales, lifting gross margins 524 basis points to 59% despite wider losses. The company narrowed its full-year ...

CONCORD, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a clinical-stage medical technology company — announced the appointment of Steven Russell, MD, Ph.D., to the role of Chief ...

On Friday, William Blair initiated coverage on Tandem Diabetes Care Inc. TNDM and Beta Bionics Inc BBNX, noting that both ...

Shares of Beta Bionics (BBNX) have seen a very successful public offering, trading some 40% above the offer price, as investors are upbeat on the prospects for the provider of new treatment options ...

Medtech’s IPO market has seen massive dips and slight spikes in activity. In the most recent Pulse of the Industry Report, EY analysts said there was a bit of a resurgence in the IPO market from July ...